Literature DB >> 30690276

Detecting cognitive impairment in patients with schizophrenia with the Addenbrooke's Cognitive Examination.

Thammanard Charernboon1, Piyanud Chompookard2.   

Abstract

OBJECTIVE: To assess the feasibility of the Addenbrooke's Cognitive Examination III (ACE) in detecting cognitive deficits in people with schizophrenia and to examine the profile of cognitive impairments.
METHODS: There were 32 participants with schizophrenia and 32 normal controls were carried out at Thammasat University Hospital, Thailand. They were matched 1:1 using comparable age and educational level. All participants completed the ACE.
RESULTS: Schizophrenia patients had lower mean totals in their ACE scores than normal controls [82.9(8.4) vs 89.6(6.1), p < 0.001]. Analysis of the individual cognitive subdomains demonstrated that patients performed significantly worse than normal controls on three subdomains: attention (p 0.007), memory (p 0.003) and verbal fluency (p 0.018). There were no statistically significant differences in the language (p 0.223) and visuospatial ability domains (p 0.055).
CONCLUSIONS: The ACE can detect the cognitive deficits in people with schizophrenia. They had a lower cognitive function compared to the normal controls.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Addenbrooke’s Cognitive Examination; Cognitive assessment; Cognitive function; Schizophrenia

Mesh:

Year:  2019        PMID: 30690276     DOI: 10.1016/j.ajp.2019.01.006

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018



北京卡尤迪生物科技股份有限公司 © 2022-2023.